Co-Op, In Vitro Biology
Moderna
Summary
Moderna is seeking a highly motivated co-op with a strong interest in cell biology, assay development, and drug delivery to join our team. This is a full-time co-op based in Cambridge, MA from January 18, 2027 – June 25, 2027. Candidates must be available for the entire duration of the program.
Job description
Here’s What You’ll Do
- Develop and execute plate-based cell assays and microscopy workflows to evaluate novel delivery technologies.
- Optimize cell-based assays for robustness, reproducibility, and scalability by systematically evaluating key cell culture and assay parameters.
- Establish experimental controls, quality criteria, and standardized workflows to ensure consistent assay execution and interpretation.
- Design and conduct follow-up studies to characterize promising candidates in relevant cellular models.
- Apply molecular and cell biology approaches to investigate biological factors influencing delivery performance.
- Execute and troubleshoot experimental protocols, adapt new methods, and leverage scientific literature to guide experimental design.
- Analyze, interpret, document, and communicate experimental results to multidisciplinary project teams.
- Collaborate with scientists across multiple disciplines to advance research objectives.
Here’s What You’ll Need (Minimum Qualifications)
- Currently pursuing a BS, MS, or equivalent degree in cell biology, molecular biology, bioengineering, biomedical engineering, biochemistry, pharmaceutical sciences, or a related scientific discipline.
- Hands-on laboratory experience with mammalian cell culture and a strong foundation in cell and molecular biology.
- Experience with cell-based assays and plate-based experimental workflows.
- Ability to organize and document experimental work clearly and maintain accurate laboratory records.
- Strong communication skills and enthusiasm for presenting and discussing scientific results.
- Ability to work both independently and collaboratively in a multidisciplinary, fast-paced research environment.
Here’s What You’ll Bring to the Table (Preferred Qualifications)
- GPA of 3.5 (on a 4.0 scale) or equivalent academic achievement.
- Experience with fluorescence microscopy or imaging techniques.
- Familiarity with quantitative data analysis and visualization using tools such as Excel, GraphPad Prism, or similar software.
- Demonstrated ability to troubleshoot experiments, think critically about experimental results, and learn new laboratory techniques.
Requirements
- Currently pursuing a BS, MS, or equivalent degree in cell biology, molecular biology, bioengineering, biomedical engineering, biochemistry, pharmaceutical sciences, or a related scientific discipline
- Hands-on laboratory experience with mammalian cell culture and a strong foundation in cell and molecular biology
- Experience with cell-based assays and plate-based experimental workflows
- Ability to organize and document experimental work clearly and maintain accurate laboratory records
- Strong communication skills and enthusiasm for presenting and discussing scientific results
- Ability to work both independently and collaboratively in a multidisciplinary, fast-paced research environment
- GPA of 3.5 (on a 4.0 scale) or equivalent academic achievement
- Experience with fluorescence microscopy or imaging techniques
- Familiarity with quantitative data analysis and visualization using tools such as Excel, GraphPad Prism, or similar software
- Demonstrated ability to troubleshoot experiments, think critically about experimental results, and learn new laboratory techniques
Benefits
- Meditation and mindfulness classes
- Subsidized commuter benefits
- Paid time off
- Vacation
- Sick time
- Holidays
- Volunteer days
- Discretionary year-end shutdown
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.